Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
Lassa virus can cause haemorrhagic fever for which no specific treatment currently exists. Here the authors have cloned 113 monoclonal antibodies from the survivors of Lassa infection and show that the majority of neutralizing antibodies target a complex of GP1 and GP2 viral proteins.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d40aae7302c442638a735c72e28f07c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d40aae7302c442638a735c72e28f07c6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d40aae7302c442638a735c72e28f07c62021-12-02T15:35:41ZMost neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits10.1038/ncomms115442041-1723https://doaj.org/article/d40aae7302c442638a735c72e28f07c62016-05-01T00:00:00Zhttps://doi.org/10.1038/ncomms11544https://doaj.org/toc/2041-1723Lassa virus can cause haemorrhagic fever for which no specific treatment currently exists. Here the authors have cloned 113 monoclonal antibodies from the survivors of Lassa infection and show that the majority of neutralizing antibodies target a complex of GP1 and GP2 viral proteins.James E. RobinsonKathryn M. HastieRobert W. CrossRachael E. YenniDeborah H. ElliottJulie A. RouelleChandrika B. KannadkaAshley A. SmiraCourtney E. GarryBenjamin T. BradleyHaini YuJeffrey G. ShafferMatt L. BoisenJessica N. HartnettMichelle A. ZandonattiMegan M. RowlandMegan L. HeinrichLuis Martínez-SobridoBenson ChengJuan C. de la TorreKristian G. AndersenAugustine GobaMambu MomohMohamed FullahMichael GbakieLansana KannehVeronica J. KoromaRichard FonnieSimbirie C. JallohBrima KargboMohamed A. VandiMomoh GbetuwaOdia IkponmwosaDanny A. AsogunPeter O. OkokhereOnikepe A. FollarinJohn S. SchieffelinKelly R. PittsJoan B. GeisbertPeter C. KulakoskiRussell B. WilsonChristian T. HappiPardis C. SabetiSahr M. GevaoS. Humarr KhanDonald S. GrantThomas W. GeisbertErica Ollmann SaphireLuis M. BrancoRobert F. GarryNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-14 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q James E. Robinson Kathryn M. Hastie Robert W. Cross Rachael E. Yenni Deborah H. Elliott Julie A. Rouelle Chandrika B. Kannadka Ashley A. Smira Courtney E. Garry Benjamin T. Bradley Haini Yu Jeffrey G. Shaffer Matt L. Boisen Jessica N. Hartnett Michelle A. Zandonatti Megan M. Rowland Megan L. Heinrich Luis Martínez-Sobrido Benson Cheng Juan C. de la Torre Kristian G. Andersen Augustine Goba Mambu Momoh Mohamed Fullah Michael Gbakie Lansana Kanneh Veronica J. Koroma Richard Fonnie Simbirie C. Jalloh Brima Kargbo Mohamed A. Vandi Momoh Gbetuwa Odia Ikponmwosa Danny A. Asogun Peter O. Okokhere Onikepe A. Follarin John S. Schieffelin Kelly R. Pitts Joan B. Geisbert Peter C. Kulakoski Russell B. Wilson Christian T. Happi Pardis C. Sabeti Sahr M. Gevao S. Humarr Khan Donald S. Grant Thomas W. Geisbert Erica Ollmann Saphire Luis M. Branco Robert F. Garry Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
description |
Lassa virus can cause haemorrhagic fever for which no specific treatment currently exists. Here the authors have cloned 113 monoclonal antibodies from the survivors of Lassa infection and show that the majority of neutralizing antibodies target a complex of GP1 and GP2 viral proteins. |
format |
article |
author |
James E. Robinson Kathryn M. Hastie Robert W. Cross Rachael E. Yenni Deborah H. Elliott Julie A. Rouelle Chandrika B. Kannadka Ashley A. Smira Courtney E. Garry Benjamin T. Bradley Haini Yu Jeffrey G. Shaffer Matt L. Boisen Jessica N. Hartnett Michelle A. Zandonatti Megan M. Rowland Megan L. Heinrich Luis Martínez-Sobrido Benson Cheng Juan C. de la Torre Kristian G. Andersen Augustine Goba Mambu Momoh Mohamed Fullah Michael Gbakie Lansana Kanneh Veronica J. Koroma Richard Fonnie Simbirie C. Jalloh Brima Kargbo Mohamed A. Vandi Momoh Gbetuwa Odia Ikponmwosa Danny A. Asogun Peter O. Okokhere Onikepe A. Follarin John S. Schieffelin Kelly R. Pitts Joan B. Geisbert Peter C. Kulakoski Russell B. Wilson Christian T. Happi Pardis C. Sabeti Sahr M. Gevao S. Humarr Khan Donald S. Grant Thomas W. Geisbert Erica Ollmann Saphire Luis M. Branco Robert F. Garry |
author_facet |
James E. Robinson Kathryn M. Hastie Robert W. Cross Rachael E. Yenni Deborah H. Elliott Julie A. Rouelle Chandrika B. Kannadka Ashley A. Smira Courtney E. Garry Benjamin T. Bradley Haini Yu Jeffrey G. Shaffer Matt L. Boisen Jessica N. Hartnett Michelle A. Zandonatti Megan M. Rowland Megan L. Heinrich Luis Martínez-Sobrido Benson Cheng Juan C. de la Torre Kristian G. Andersen Augustine Goba Mambu Momoh Mohamed Fullah Michael Gbakie Lansana Kanneh Veronica J. Koroma Richard Fonnie Simbirie C. Jalloh Brima Kargbo Mohamed A. Vandi Momoh Gbetuwa Odia Ikponmwosa Danny A. Asogun Peter O. Okokhere Onikepe A. Follarin John S. Schieffelin Kelly R. Pitts Joan B. Geisbert Peter C. Kulakoski Russell B. Wilson Christian T. Happi Pardis C. Sabeti Sahr M. Gevao S. Humarr Khan Donald S. Grant Thomas W. Geisbert Erica Ollmann Saphire Luis M. Branco Robert F. Garry |
author_sort |
James E. Robinson |
title |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
title_short |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
title_full |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
title_fullStr |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
title_full_unstemmed |
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits |
title_sort |
most neutralizing human monoclonal antibodies target novel epitopes requiring both lassa virus glycoprotein subunits |
publisher |
Nature Portfolio |
publishDate |
2016 |
url |
https://doaj.org/article/d40aae7302c442638a735c72e28f07c6 |
work_keys_str_mv |
AT jameserobinson mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT kathrynmhastie mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT robertwcross mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT rachaeleyenni mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT deborahhelliott mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT juliearouelle mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT chandrikabkannadka mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT ashleyasmira mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT courtneyegarry mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT benjamintbradley mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT hainiyu mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT jeffreygshaffer mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT mattlboisen mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT jessicanhartnett mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT michelleazandonatti mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT meganmrowland mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT meganlheinrich mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT luismartinezsobrido mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT bensoncheng mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT juancdelatorre mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT kristiangandersen mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT augustinegoba mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT mambumomoh mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT mohamedfullah mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT michaelgbakie mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT lansanakanneh mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT veronicajkoroma mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT richardfonnie mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT simbiriecjalloh mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT brimakargbo mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT mohamedavandi mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT momohgbetuwa mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT odiaikponmwosa mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT dannyaasogun mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT peterookokhere mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT onikepeafollarin mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT johnsschieffelin mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT kellyrpitts mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT joanbgeisbert mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT peterckulakoski mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT russellbwilson mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT christianthappi mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT pardiscsabeti mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT sahrmgevao mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT shumarrkhan mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT donaldsgrant mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT thomaswgeisbert mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT ericaollmannsaphire mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT luismbranco mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits AT robertfgarry mostneutralizinghumanmonoclonalantibodiestargetnovelepitopesrequiringbothlassavirusglycoproteinsubunits |
_version_ |
1718386504550580224 |